CN114075506B - Urine exosome extraction reagent tube and production method - Google Patents
Urine exosome extraction reagent tube and production method Download PDFInfo
- Publication number
- CN114075506B CN114075506B CN202010848912.XA CN202010848912A CN114075506B CN 114075506 B CN114075506 B CN 114075506B CN 202010848912 A CN202010848912 A CN 202010848912A CN 114075506 B CN114075506 B CN 114075506B
- Authority
- CN
- China
- Prior art keywords
- nanofiber membrane
- chitosan
- tube
- inner tube
- plla
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12M—APPARATUS FOR ENZYMOLOGY OR MICROBIOLOGY; APPARATUS FOR CULTURING MICROORGANISMS FOR PRODUCING BIOMASS, FOR GROWING CELLS OR FOR OBTAINING FERMENTATION OR METABOLIC PRODUCTS, i.e. BIOREACTORS OR FERMENTERS
- C12M23/00—Constructional details, e.g. recesses, hinges
- C12M23/02—Form or structure of the vessel
- C12M23/06—Tubular
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12M—APPARATUS FOR ENZYMOLOGY OR MICROBIOLOGY; APPARATUS FOR CULTURING MICROORGANISMS FOR PRODUCING BIOMASS, FOR GROWING CELLS OR FOR OBTAINING FERMENTATION OR METABOLIC PRODUCTS, i.e. BIOREACTORS OR FERMENTERS
- C12M33/00—Means for introduction, transport, positioning, extraction, harvesting, peeling or sampling of biological material in or from the apparatus
- C12M33/10—Means for introduction, transport, positioning, extraction, harvesting, peeling or sampling of biological material in or from the apparatus by centrifugation ; Cyclones
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12M—APPARATUS FOR ENZYMOLOGY OR MICROBIOLOGY; APPARATUS FOR CULTURING MICROORGANISMS FOR PRODUCING BIOMASS, FOR GROWING CELLS OR FOR OBTAINING FERMENTATION OR METABOLIC PRODUCTS, i.e. BIOREACTORS OR FERMENTERS
- C12M33/00—Means for introduction, transport, positioning, extraction, harvesting, peeling or sampling of biological material in or from the apparatus
- C12M33/14—Means for introduction, transport, positioning, extraction, harvesting, peeling or sampling of biological material in or from the apparatus with filters, sieves or membranes
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12M—APPARATUS FOR ENZYMOLOGY OR MICROBIOLOGY; APPARATUS FOR CULTURING MICROORGANISMS FOR PRODUCING BIOMASS, FOR GROWING CELLS OR FOR OBTAINING FERMENTATION OR METABOLIC PRODUCTS, i.e. BIOREACTORS OR FERMENTERS
- C12M47/00—Means for after-treatment of the produced biomass or of the fermentation or metabolic products, e.g. storage of biomass
- C12M47/04—Cell isolation or sorting
-
- D—TEXTILES; PAPER
- D01—NATURAL OR MAN-MADE THREADS OR FIBRES; SPINNING
- D01F—CHEMICAL FEATURES IN THE MANUFACTURE OF ARTIFICIAL FILAMENTS, THREADS, FIBRES, BRISTLES OR RIBBONS; APPARATUS SPECIALLY ADAPTED FOR THE MANUFACTURE OF CARBON FILAMENTS
- D01F8/00—Conjugated, i.e. bi- or multicomponent, artificial filaments or the like; Manufacture thereof
- D01F8/04—Conjugated, i.e. bi- or multicomponent, artificial filaments or the like; Manufacture thereof from synthetic polymers
- D01F8/14—Conjugated, i.e. bi- or multicomponent, artificial filaments or the like; Manufacture thereof from synthetic polymers with at least one polyester as constituent
-
- D—TEXTILES; PAPER
- D01—NATURAL OR MAN-MADE THREADS OR FIBRES; SPINNING
- D01F—CHEMICAL FEATURES IN THE MANUFACTURE OF ARTIFICIAL FILAMENTS, THREADS, FIBRES, BRISTLES OR RIBBONS; APPARATUS SPECIALLY ADAPTED FOR THE MANUFACTURE OF CARBON FILAMENTS
- D01F8/00—Conjugated, i.e. bi- or multicomponent, artificial filaments or the like; Manufacture thereof
- D01F8/18—Conjugated, i.e. bi- or multicomponent, artificial filaments or the like; Manufacture thereof from other substances
-
- D—TEXTILES; PAPER
- D06—TREATMENT OF TEXTILES OR THE LIKE; LAUNDERING; FLEXIBLE MATERIALS NOT OTHERWISE PROVIDED FOR
- D06M—TREATMENT, NOT PROVIDED FOR ELSEWHERE IN CLASS D06, OF FIBRES, THREADS, YARNS, FABRICS, FEATHERS OR FIBROUS GOODS MADE FROM SUCH MATERIALS
- D06M10/00—Physical treatment of fibres, threads, yarns, fabrics or fibrous goods made from such materials, e.g. by ultrasonic waves, corona discharge, irradiation, electric currents or magnetic fields; Physical treatment combined with treatment with chemical compounds or elements
- D06M10/001—Treatment with visible light, infrared or ultraviolet, X-rays
-
- D—TEXTILES; PAPER
- D06—TREATMENT OF TEXTILES OR THE LIKE; LAUNDERING; FLEXIBLE MATERIALS NOT OTHERWISE PROVIDED FOR
- D06M—TREATMENT, NOT PROVIDED FOR ELSEWHERE IN CLASS D06, OF FIBRES, THREADS, YARNS, FABRICS, FEATHERS OR FIBROUS GOODS MADE FROM SUCH MATERIALS
- D06M10/00—Physical treatment of fibres, threads, yarns, fabrics or fibrous goods made from such materials, e.g. by ultrasonic waves, corona discharge, irradiation, electric currents or magnetic fields; Physical treatment combined with treatment with chemical compounds or elements
- D06M10/04—Physical treatment combined with treatment with chemical compounds or elements
- D06M10/08—Organic compounds
- D06M10/10—Macromolecular compounds
-
- D—TEXTILES; PAPER
- D06—TREATMENT OF TEXTILES OR THE LIKE; LAUNDERING; FLEXIBLE MATERIALS NOT OTHERWISE PROVIDED FOR
- D06M—TREATMENT, NOT PROVIDED FOR ELSEWHERE IN CLASS D06, OF FIBRES, THREADS, YARNS, FABRICS, FEATHERS OR FIBROUS GOODS MADE FROM SUCH MATERIALS
- D06M15/00—Treating fibres, threads, yarns, fabrics, or fibrous goods made from such materials, with macromolecular compounds; Such treatment combined with mechanical treatment
- D06M15/19—Treating fibres, threads, yarns, fabrics, or fibrous goods made from such materials, with macromolecular compounds; Such treatment combined with mechanical treatment with synthetic macromolecular compounds
- D06M15/21—Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds
- D06M15/285—Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds of unsaturated carboxylic acid amides or imides
-
- D—TEXTILES; PAPER
- D06—TREATMENT OF TEXTILES OR THE LIKE; LAUNDERING; FLEXIBLE MATERIALS NOT OTHERWISE PROVIDED FOR
- D06M—TREATMENT, NOT PROVIDED FOR ELSEWHERE IN CLASS D06, OF FIBRES, THREADS, YARNS, FABRICS, FEATHERS OR FIBROUS GOODS MADE FROM SUCH MATERIALS
- D06M2101/00—Chemical constitution of the fibres, threads, yarns, fabrics or fibrous goods made from such materials, to be treated
- D06M2101/02—Natural fibres, other than mineral fibres
-
- D—TEXTILES; PAPER
- D06—TREATMENT OF TEXTILES OR THE LIKE; LAUNDERING; FLEXIBLE MATERIALS NOT OTHERWISE PROVIDED FOR
- D06M—TREATMENT, NOT PROVIDED FOR ELSEWHERE IN CLASS D06, OF FIBRES, THREADS, YARNS, FABRICS, FEATHERS OR FIBROUS GOODS MADE FROM SUCH MATERIALS
- D06M2101/00—Chemical constitution of the fibres, threads, yarns, fabrics or fibrous goods made from such materials, to be treated
- D06M2101/16—Synthetic fibres, other than mineral fibres
- D06M2101/30—Synthetic polymers consisting of macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds
- D06M2101/32—Polyesters
Landscapes
- Engineering & Computer Science (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Zoology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Organic Chemistry (AREA)
- Wood Science & Technology (AREA)
- Textile Engineering (AREA)
- Biotechnology (AREA)
- Biochemistry (AREA)
- Sustainable Development (AREA)
- Microbiology (AREA)
- General Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Biomedical Technology (AREA)
- Molecular Biology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Cell Biology (AREA)
- Clinical Laboratory Science (AREA)
- Toxicology (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Peptides Or Proteins (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Abstract
Description
技术领域Technical field
本发明涉及外泌体提取技术领域,特别涉及一种尿液外泌体提取试剂管及制作方法。The present invention relates to the technical field of exosome extraction, and in particular to a urine exosome extraction reagent tube and a production method.
背景技术Background technique
外泌体最早见于1981年,EGTrams等在体外培养的绵羊红细胞上清液中发现了有膜结构的小囊泡,并命名为exosome。对于外泌体的作用,当时推测为细胞排泄废物的一种方式。1996年GRaposo等发现类似于B淋巴细胞的免疫细胞也会分泌抗原呈递外泌体(antigenpresentingvesicle),所分泌的外泌体可以直接刺激效应CD4+细胞的抗肿瘤反应。2007年HValadi等进一步发现细胞之间可以通过外泌体中RNA交换遗传物质。随着有关外泌体研究越来越多,研究者发现它广泛参与了机体免疫应答、抗原呈递、细胞分化、肿瘤生长于侵袭等各种生物过程中。Exosomes were first seen in 1981. EG Trams et al. discovered small vesicles with a membrane structure in the supernatant of sheep red blood cells cultured in vitro and named them exosomes. As for the role of exosomes, it was speculated that they were a way for cells to excrete waste. In 1996, GRaposo et al. discovered that immune cells similar to B lymphocytes also secrete antigen-presenting exosomes (antigenpresentingvesicles). The secreted exosomes can directly stimulate the anti-tumor response of effector CD4+ cells. In 2007, HValadi et al. further discovered that cells can exchange genetic material through RNA in exosomes. As more and more studies are conducted on exosomes, researchers have found that they are widely involved in various biological processes such as the body's immune response, antigen presentation, cell differentiation, tumor growth and invasion, etc.
几乎所有类型的细胞都可以分泌外泌体,同时外泌体也广泛存在于体液中,包括血液、眼泪、尿液、唾液、乳汁、腹水等。外泌体所携带核酸(microRNA、lncRNA、circRNA、mRNA、tRNA等)、蛋白、胆固醇等物质能被外泌体双层膜有效包裹,因此可抵抗各种因素的降解,使外泌体在体液中稳定存在,随着近年来对外泌体研究的深入,临床上在发现在癌症发病的早期阶段肿瘤病人体液中的外泌体与正常人外泌体所携带的生物物质就存在明显差异,因此对体液中外泌体提取有望成为癌症早期诊断技术,由于人体结构的特殊性,人尿液中的外泌体可作为肾脏疾病、前列腺疾病、膀胱疾病的临床检测的新型生物标记物。Almost all types of cells can secrete exosomes, and exosomes are also widely found in body fluids, including blood, tears, urine, saliva, breast milk, ascites, etc. The nucleic acids (microRNA, lncRNA, circRNA, mRNA, tRNA, etc.), proteins, cholesterol and other substances carried by exosomes can be effectively wrapped by the double-layer membrane of exosomes, so they can resist degradation by various factors, allowing exosomes to remain in body fluids With the in-depth research on exosomes in recent years, it has been clinically discovered that in the early stages of cancer, there are significant differences in the biological substances carried by exosomes in the body fluids of tumor patients and those carried by normal human exosomes. Therefore, The extraction of exosomes from body fluids is expected to become an early diagnosis technology for cancer. Due to the particularity of the human body structure, exosomes in human urine can be used as new biomarkers for clinical detection of kidney disease, prostate disease, and bladder disease.
现阶段对尿液外泌体的提取主要有超高速离心法,磁珠抗体捕获法,色相柱尺寸排阻法,PEG沉淀过柱法,正电荷捕获法。超高速离心法:超速离心法是目前最常用的外泌体纯化手段,通过高速离心将大小相同的囊泡从样本中沉淀并纯化出来。需在离心机中以100,000-200,000xg离心沉淀(含有外泌体)120分钟。磁珠抗体捕获法:外泌体膜上磷酯酰丝氨酸(PS)特异性的结合Tim4锚定的磁珠,再经过含有EDTA的洗脱缓冲液进行分离。色相柱尺寸排阻法:根据外泌体的粒径大小将外泌体和和其他粒径大小的蛋白质分离。PEG沉淀过柱法:通过PEG沉淀外泌体,再通过过离子柱将PEG去除,最后用高盐溶液洗脱外泌体。正电荷捕获法:在固相载体上覆盖带正电荷的涂层,再通过正负电荷吸引捕获带负电荷的外泌体。At present, the main methods for extracting urinary exosomes include ultra-high-speed centrifugation, magnetic bead antibody capture method, color column size exclusion method, PEG precipitation column method, and positive charge capture method. Ultra-high-speed centrifugation: Ultra-fast centrifugation is currently the most commonly used exosome purification method. Vesicles of the same size are precipitated and purified from the sample through high-speed centrifugation. The pellet (containing exosomes) needs to be centrifuged in a centrifuge at 100,000-200,000xg for 120 minutes. Magnetic bead antibody capture method: Phosphatidylserine (PS) specifically binds Tim4-anchored magnetic beads on the exosome membrane, and then separates through an elution buffer containing EDTA. Color column size exclusion method: Separate exosomes and proteins of other particle sizes based on the particle size of exosomes. PEG precipitation column method: Precipitate exosomes with PEG, remove PEG through an ion column, and finally elute exosomes with high-salt solution. Positive charge capture method: a solid-phase carrier is covered with a positively charged coating, and then negatively charged exosomes are captured through positive and negative charge attraction.
现有的外泌体技术均耗时(40min-10小时不等),存在不同程度的提取试剂的污染(如PEG沉淀法中沉淀试剂残留,如用过柱法中高盐试剂的残留,如磁珠吸附法中磁珠锚链抗体的污染,洗脱液EDTA的污染),正电荷捕获虽然不造成提取试剂的污染,但对粒径为大于200nm的微囊泡和粒径在50-200nm的外泌体无法区分,色相柱尺寸排阻法对尿液外泌体提取效率低,大量的尿液中含有的大分子物质容易堵塞色相柱,且容易被粒径大约为100nm左右的脂蛋白污染。Existing exosome technologies are time-consuming (ranging from 40 minutes to 10 hours), and there are varying degrees of contamination of the extraction reagents (such as residues of precipitation reagents in the PEG precipitation method, residues of high-salt reagents in the column method, such as magnetic In the bead adsorption method, the contamination of the anchor chain antibody of the magnetic beads and the contamination of the eluent EDTA), although positive charge capture does not cause contamination of the extraction reagent, it will affect microvesicles with a particle size greater than 200nm and particles with a particle size of 50-200nm. Exosomes cannot be distinguished. The extraction efficiency of urine exosomes by the color column size exclusion method is low. A large amount of macromolecules contained in urine can easily block the color column and be easily contaminated by lipoproteins with a particle size of about 100 nm. .
发明内容Contents of the invention
本发明要解决的技术问题是克服现有技术的缺陷,提供一种尿液外泌体提取试剂管,本发明的另一目的是提供一种制作上述尿液外泌体提取试剂管制作方法。The technical problem to be solved by the present invention is to overcome the defects of the prior art and provide a urine exosome extraction reagent tube. Another object of the present invention is to provide a method for making the above-mentioned urine exosome extraction reagent tube.
为了解决上述技术问题,本发明提供了如下的技术方案:In order to solve the above technical problems, the present invention provides the following technical solutions:
本发明一种尿液外泌体提取试剂管,包括盖帽、外管和内管,所述外管的顶端表面螺纹套接有盖帽,所述外管的内部套接有内管,所述内管的内壁设置有纳米纤维膜。A urine exosome extraction reagent tube of the present invention includes a cap, an outer tube and an inner tube. The top surface of the outer tube is threaded with a cap, and the inside of the outer tube is threaded with an inner tube. The inner wall of the tube is provided with a nanofiber membrane.
作为本发明的一种优选技术方案,所述外管和内管的外壁均设置有容量刻度线,且外管和内管均为聚碳酸酯材料制成。As a preferred technical solution of the present invention, the outer walls of the outer tube and the inner tube are both provided with capacity scales, and both the outer tube and the inner tube are made of polycarbonate material.
本发明提供的制作上述尿液外泌体提取试剂管制作方法,制作步骤如下:The invention provides a method for making the above-mentioned urine exosome extraction reagent tube. The making steps are as follows:
A:将分子量9万的PLLA溶解后和壳聚糖按5:1的比例溶解于三氟乙醇溶液制备得到浓度为8wt%的混合溶液,并在25-30℃的室温下充分溶解PLLA和壳聚糖混合液;A: Dissolve PLLA with a molecular weight of 90,000 and chitosan in a trifluoroethanol solution at a ratio of 5:1 to prepare a mixed solution with a concentration of 8wt%, and fully dissolve PLLA and chitosan at room temperature of 25-30°C. polysaccharide mixture;
B:用27g针头在8-10kV的高电压下,以0.5–1.0ml/h的速度推进注射器,用静置平面接收纳米纤维膜;B: Use a 27g needle at a high voltage of 8-10kV to advance the syringe at a speed of 0.5-1.0ml/h, and use a static surface to receive the nanofiber membrane;
C:将纳米纤维膜放入乙醇和间甲苯酚的混合溶剂中,在25-30℃的室温溶脱60min后干燥;C: Put the nanofiber membrane into a mixed solvent of ethanol and m-cresol, dissolve it at room temperature of 25-30°C for 60 minutes and then dry it;
D:将膜放入1.5mol/L氢氧化钠甲醇水溶液浸泡30min,获得多孔PLLA/壳聚糖纳米纤维膜;D: Soak the membrane in 1.5 mol/L sodium hydroxide methanol aqueous solution for 30 minutes to obtain a porous PLLA/chitosan nanofiber membrane;
E:将50mg阳离子聚丙烯酰胺添加至100ml去离子水中,加热至50℃下搅拌,用NaOH调节出pH=7.0的溶液,将多孔PLLA/壳聚糖纳米纤维膜浸入溶液中,在25-30℃的室温搅拌24小时后,干燥;E: Add 50 mg of cationic polyacrylamide to 100 ml of deionized water, heat to 50°C and stir, use NaOH to adjust the solution to pH=7.0, immerse the porous PLLA/chitosan nanofiber membrane into the solution, and wait for 25-30 After stirring at room temperature of ℃ for 24 hours, dry;
F:用紫外灯照射3小时,对阳离子聚丙烯酰胺与壳聚糖进行交联反应,则得到带正电荷多孔PLLA/壳聚糖纳米纤维膜;F: Use UV light for 3 hours to cross-link the cationic polyacrylamide and chitosan to obtain a positively charged porous PLLA/chitosan nanofiber membrane;
G:将正电荷多孔PLLA/壳聚糖纳米纤维膜粘附在内管的内壁,将内管3与外管组合后拧上盖帽即可。G: Adhere the positively charged porous PLLA/chitosan nanofiber membrane to the inner wall of the inner tube, combine the inner tube 3 with the outer tube and screw on the cap.
以上制作方法中,步骤C中乙醇和间甲苯酚的比例为1:1。In the above production method, the ratio of ethanol and m-cresol in step C is 1:1.
以上制作方法中,步骤D当中氢氧化钠甲醇水溶液的甲醇与水比例为1∶1。In the above production method, the ratio of methanol to water in the sodium hydroxide methanol aqueous solution in step D is 1:1.
与现有技术相比,本发明的有益效果如下:Compared with the prior art, the beneficial effects of the present invention are as follows:
本发明可在短时间能完成整个反应,无需长时间等待;利用正负电荷吸引原理,不但无分离试剂的污染,还可以除掉尿液中粒径大小为50-200nm不带电荷的脂蛋白;正电荷多孔纳米纤维膜上的孔径大小为50-200nm左右,可得到高纯度的粒径大小为50-200nm的外泌体,防止其他粒径微囊泡的污染;正电荷多孔纳米纤维膜上多孔的结构大大提高了膜与样品的接触面积,增大尿液外泌体提取效率。The present invention can complete the entire reaction in a short time without waiting for a long time; by utilizing the principle of positive and negative charge attraction, not only is there no pollution from the separation reagent, but it can also remove uncharged lipoproteins with a particle size of 50-200 nm in urine. ; The pore size on the positively charged porous nanofiber membrane is about 50-200nm, and high-purity exosomes with a particle size of 50-200nm can be obtained to prevent contamination of microvesicles with other particle sizes; Positively charged porous nanofiber membrane The porous structure greatly increases the contact area between the membrane and the sample, increasing the extraction efficiency of urine exosomes.
附图说明Description of the drawings
附图用来提供对本发明的进一步理解,并且构成说明书的一部分,与本发明的实施例一起用于解释本发明,并不构成对本发明的限制。在附图中:The drawings are used to provide a further understanding of the present invention and constitute a part of the specification. They are used to explain the present invention together with the embodiments of the present invention and do not constitute a limitation of the present invention. In the attached picture:
图1是本发明的整体结构示意图;Figure 1 is a schematic diagram of the overall structure of the present invention;
图2是图1结构截面图;Figure 2 is a cross-sectional view of the structure of Figure 1;
图3是本发明的正电荷多孔PLLA/壳聚糖纳米纤维膜制作流程图;Figure 3 is a production flow chart of the positively charged porous PLLA/chitosan nanofiber membrane of the present invention;
图4是本发明的尿液外泌体提取的流程图;Figure 4 is a flow chart of urine exosome extraction according to the present invention;
图中:1、盖帽;2、外管;3、内管;4、纳米纤维膜。In the picture: 1. Cap; 2. Outer tube; 3. Inner tube; 4. Nanofiber membrane.
具体实施方式Detailed ways
以下结合附图对本发明的优选实施例进行说明,应当理解,此处所描述的优选实施例仅用于说明和解释本发明,并不用于限定本发明。The preferred embodiments of the present invention will be described below with reference to the accompanying drawings. It should be understood that the preferred embodiments described here are only used to illustrate and explain the present invention, and are not intended to limit the present invention.
实施例1Example 1
如图1-4所示,本发明提供一种尿液外泌体提取试剂管,包括盖帽1、外管2和内管3,外管2的顶端表面螺纹套接有盖帽1,外管2的内部套接有内管3,内管3的内壁设置有纳米纤维膜4。As shown in Figures 1-4, the present invention provides a urine exosome extraction reagent tube, which includes a cap 1, an outer tube 2 and an inner tube 3. The top surface of the outer tube 2 is threaded with the cap 1, and the outer tube 2 An inner tube 3 is sleeved inside, and a nanofiber membrane 4 is provided on the inner wall of the inner tube 3 .
外管2和内管3的外壁均设置有容量刻度线,且外管2和内管3均为聚碳酸酯材料制成。The outer walls of the outer tube 2 and the inner tube 3 are both provided with capacity scales, and both the outer tube 2 and the inner tube 3 are made of polycarbonate material.
尿液外泌体提取试剂管制作方法,制作步骤如下:Urine exosome extraction reagent tube production method, the production steps are as follows:
A:将分子量9万的PLLA溶解后和壳聚糖按5:1的比例溶解于三氟乙醇溶液制备得到浓度为8wt%的混合溶液,并在25-30℃的室温下充分溶解PLLA和壳聚糖混合液;A: Dissolve PLLA with a molecular weight of 90,000 and chitosan in a trifluoroethanol solution at a ratio of 5:1 to prepare a mixed solution with a concentration of 8wt%, and fully dissolve PLLA and chitosan at room temperature of 25-30°C. polysaccharide mixture;
B:用27g针头在8-10kV的高电压下,以0.5–1.0ml/h的速度推进注射器,用静置平面接收纳米纤维膜;B: Use a 27g needle at a high voltage of 8-10kV to advance the syringe at a speed of 0.5-1.0ml/h, and use a static surface to receive the nanofiber membrane;
C:将纳米纤维膜放入乙醇和间甲苯酚的混合溶剂中,在25-30℃的室温溶脱60min后干燥;C: Put the nanofiber membrane into a mixed solvent of ethanol and m-cresol, dissolve it at room temperature of 25-30°C for 60 minutes and then dry it;
D:将膜放入1.5mol/L氢氧化钠甲醇水溶液浸泡30min,获得多孔PLLA/壳聚糖纳米纤维膜;D: Soak the membrane in 1.5 mol/L sodium hydroxide methanol aqueous solution for 30 minutes to obtain a porous PLLA/chitosan nanofiber membrane;
E:将50mg阳离子聚丙烯酰胺添加至100ml去离子水中,加热至50℃下搅拌,用NaOH调节出pH=7.0的溶液,将多孔PLLA/壳聚糖纳米纤维膜浸入溶液中,在25-30℃的室温搅拌24小时后,干燥;E: Add 50 mg of cationic polyacrylamide to 100 ml of deionized water, heat to 50°C and stir, use NaOH to adjust the solution to pH=7.0, immerse the porous PLLA/chitosan nanofiber membrane into the solution, and wait for 25-30 After stirring at room temperature of ℃ for 24 hours, dry;
F:用紫外灯照射3小时,对阳离子聚丙烯酰胺与壳聚糖进行交联反应,则得到带正电荷多孔PLLA/壳聚糖纳米纤维膜;F: Use UV light for 3 hours to cross-link the cationic polyacrylamide and chitosan to obtain a positively charged porous PLLA/chitosan nanofiber membrane;
G:将正电荷多孔PLLA/壳聚糖纳米纤维膜粘附在内管3的内壁,将内管3与外管2组合后拧上盖帽1即可。G: Adhere the positively charged porous PLLA/chitosan nanofiber membrane to the inner wall of the inner tube 3, combine the inner tube 3 and the outer tube 2 and screw on the cap 1.
进一步的,步骤C中乙醇和间甲苯酚的比例为1:1。Further, the ratio of ethanol and m-cresol in step C is 1:1.
步骤D当中氢氧化钠甲醇水溶液的甲醇与水比例为1∶1。In step D, the ratio of methanol to water in the sodium hydroxide methanol aqueous solution is 1:1.
具体的,内管3内壁的纳米纤维膜4为正电荷多孔纳米纤维膜,使用时首先用5ml磷酸盐缓冲液洗涤纳米纤维膜4一次后,将10ml尿液喷洒在纳米纤维膜4上将盖帽1盖合,以1000rpm的转速,进行离心1min去废液,再加入500ul磷酸盐缓冲液轻轻洗膜一次,吸去并丢掉洗涤液,以清除黏附在膜上大于200nm的微囊泡成分,最后加入500ul磷酸盐缓冲液反复冲洗纳米纤维膜4五次,以1000rpm的转速,进行离心1min,收集洗膜液(50-200nm直径外泌体)。Specifically, the nanofiber membrane 4 on the inner wall of the inner tube 3 is a positively charged porous nanofiber membrane. When used, the nanofiber membrane 4 is washed once with 5 ml of phosphate buffer, and then 10 ml of urine is sprayed on the nanofiber membrane 4 to cap it. 1. Close the lid and centrifuge for 1 minute at 1000 rpm to remove the waste liquid. Then add 500ul of phosphate buffer to gently wash the membrane once. Aspirate and discard the washing liquid to remove microvesicles larger than 200nm adhered to the membrane. Finally, add 500 ul of phosphate buffer to wash the nanofiber membrane 4 times and five times, centrifuge for 1 minute at 1000 rpm, and collect the membrane washing fluid (exosomes with a diameter of 50-200 nm).
本发明可在短时间能完成整个反应,无需长时间等待;利用正负电荷吸引原理,不但无分离试剂的污染,还可以除掉尿液中粒径大小为50-200nm不带电荷的脂蛋白;正电荷多孔纳米纤维膜上的孔径大小为50-200nm左右,可得到高纯度的粒径大小为50-200nm的外泌体,防止其他粒径微囊泡的污染;正电荷多孔纳米纤维膜上多孔的结构大大提高了膜与样品的接触面积,增大尿液外泌体提取效率。The present invention can complete the entire reaction in a short time without waiting for a long time; by utilizing the principle of positive and negative charge attraction, not only is there no pollution from the separation reagent, but it can also remove uncharged lipoproteins with a particle size of 50-200 nm in urine. ; The pore size on the positively charged porous nanofiber membrane is about 50-200nm, and high-purity exosomes with a particle size of 50-200nm can be obtained to prevent contamination of microvesicles with other particle sizes; Positively charged porous nanofiber membrane The porous structure greatly increases the contact area between the membrane and the sample, increasing the extraction efficiency of urine exosomes.
最后应说明的是:以上所述仅为本发明的优选实施例而已,并不用于限制本发明,尽管参照前述实施例对本发明进行了详细的说明,对于本领域的技术人员来说,其依然可以对前述各实施例所记载的技术方案进行修改,或者对其中部分技术特征进行等同替换。凡在本发明的精神和原则之内,所作的任何修改、等同替换、改进等,均应包含在本发明的保护范围之内。Finally, it should be noted that the above are only preferred embodiments of the present invention and are not intended to limit the present invention. Although the present invention has been described in detail with reference to the foregoing embodiments, for those skilled in the art, it is still The technical solutions described in the foregoing embodiments may be modified, or some of the technical features may be equivalently replaced. Any modifications, equivalent substitutions, improvements, etc. made within the spirit and principles of the present invention shall be included in the protection scope of the present invention.
Claims (4)
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN202010848912.XA CN114075506B (en) | 2020-08-21 | 2020-08-21 | Urine exosome extraction reagent tube and production method |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN202010848912.XA CN114075506B (en) | 2020-08-21 | 2020-08-21 | Urine exosome extraction reagent tube and production method |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN114075506A CN114075506A (en) | 2022-02-22 |
| CN114075506B true CN114075506B (en) | 2023-11-17 |
Family
ID=80282373
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN202010848912.XA Active CN114075506B (en) | 2020-08-21 | 2020-08-21 | Urine exosome extraction reagent tube and production method |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN114075506B (en) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN115786107A (en) * | 2022-12-14 | 2023-03-14 | 深圳市寰宇生物科技有限公司 | Efficient preparation device and method for exosome |
| CN117224747A (en) * | 2023-09-05 | 2023-12-15 | 四川大学华西医院 | An exosome-functionalized asymmetric fibrous scaffold that guides hard and soft tissue regeneration and its preparation method |
Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN106283396A (en) * | 2016-08-22 | 2017-01-04 | 王利萍 | A kind of preparation method of porous chitosan fibrous membrane |
| CN107254430A (en) * | 2017-08-11 | 2017-10-17 | 上海浦美生物医药科技有限公司 | A kind of method based on positive charge adsorbing separation excretion body |
| CN209485829U (en) * | 2018-08-16 | 2019-10-11 | 南方医科大学 | A device for enriching urine exosomes that can be used in hospitals and homes |
-
2020
- 2020-08-21 CN CN202010848912.XA patent/CN114075506B/en active Active
Patent Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN106283396A (en) * | 2016-08-22 | 2017-01-04 | 王利萍 | A kind of preparation method of porous chitosan fibrous membrane |
| CN107254430A (en) * | 2017-08-11 | 2017-10-17 | 上海浦美生物医药科技有限公司 | A kind of method based on positive charge adsorbing separation excretion body |
| CN209485829U (en) * | 2018-08-16 | 2019-10-11 | 南方医科大学 | A device for enriching urine exosomes that can be used in hospitals and homes |
Non-Patent Citations (2)
| Title |
|---|
| A promising approach toward efficient isolation of the exosomes by core–shell PCL‑gelatin electrospun nanofibers;Fatemeh Barati1;Bioprocess and Biosystems Engineering;参见全文 * |
| Novel label-free method for extracellular-vesicle enrichment from biological fluids and cell culture medium;Prateek Singh et al;ISEV2018 abstract book,,Journal of Extracellular Vesicles;第223页,PS04.14 * |
Also Published As
| Publication number | Publication date |
|---|---|
| CN114075506A (en) | 2022-02-22 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US20220349901A1 (en) | Lectin-macromolecule carrier coupling complex for separating glycosylated exosome in clinical sample | |
| CN103820431B (en) | Nucleic acid extraction purification process and kit based on nanometer magnetic bead | |
| CN111253491A (en) | A lectin-magnetic carrier conjugated complex for isolation of glycosylated exosomes from clinical samples | |
| WO2021128678A1 (en) | Method for simultaneously detecting protein, rna and exosome membrane protein in exosome | |
| CN110231207B (en) | Method for separating exosome | |
| CN113101737B (en) | Affinity tangential flow filtration system, construction method thereof, exosome extraction method and application | |
| CN114075506B (en) | Urine exosome extraction reagent tube and production method | |
| CN106754292A (en) | For the single-stranded separators of DNA and separation method of pyrosequencing | |
| CN114540271A (en) | Method for purifying plant exosomes | |
| CN110514489B (en) | Biological coating for capturing circulating tumor cells by specific whole blood for cancer monitoring and preparation method thereof | |
| CN112852725B (en) | Preparation method and application for extracting and purifying stem cell exosome by using protein cross-linked nano affinity microspheres | |
| CN113388575A (en) | Preparation method of mesenchymal stem cell exosome for skin injury repair | |
| CN114397388B (en) | Urine exosome extraction kit based on combination of PEG precipitation method and SEC column method and application | |
| CN116083364A (en) | Method for obtaining exosomes with different sizes based on ultrafiltration device | |
| CN104062428A (en) | Kit for detecting circulating tumor cells | |
| CN103571751B (en) | Method for enriching and purifying two insects in water and method for measuring content of insects | |
| CN112195175A (en) | Nucleic acid extraction method based on graphene oxide | |
| CN106970225A (en) | A kind of kit of application CD45 immunofluorescences joint probe identification circulating tumor cells of CEP 8 and its application | |
| CN112980006A (en) | Protein cross-linked nano affinity microsphere, preparation method and application | |
| CN112094809A (en) | Method for extracting exosome from serum or plasma | |
| CN107561265A (en) | A kind of separation of solid and liquid composite membrane and preparation method thereof | |
| CN209485831U (en) | Urine extracellular vesicle enrichment device for hospital use | |
| CN114184662B (en) | A MOF electrochemical sensor for exosome analysis and its preparation and application | |
| CN115232790B (en) | Pollen particles, preparation method, biological functional material using the same and application thereof | |
| CN107304413A (en) | A kind of excretion body quick separating and the kit of purifying |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PB01 | Publication | ||
| PB01 | Publication | ||
| SE01 | Entry into force of request for substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| GR01 | Patent grant | ||
| GR01 | Patent grant |